4.5 Review

1 A Systematic Review of miR-29 in Cancer

Journal

MOLECULAR THERAPY-ONCOLYTICS
Volume 12, Issue -, Pages 173-194

Publisher

CELL PRESS
DOI: 10.1016/j.omto.2018.12.011

Keywords

-

Funding

  1. American Cancer Society [RSG-18-105-01-RMC]
  2. Elsa U. Pardee Foundation
  3. IU Simon Cancer Center
  4. NCI [F31-CA213731-01A1]

Ask authors/readers for more resources

MicroRNAs (miRNA) are small non-coding RNAs (similar to 22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29's functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available